The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
NADPH Oxidases in Vascular Pathology
Open accessAbstract
SIGNIFICANCE: Reactive oxygen species (ROS) play a critical role in vascular disease. While there are many possible sources of ROS, nicotinamide adenine dinucleotide phosphate (NADPH) oxidases play a central role. They are a source of "kindling radicals," which affect other enzymes, such as nitric oxide synthase endothelial nitric oxide synthase or xanthine oxidase. This is important, as risk factors for atherosclerosis (hypertension, diabetes, hypercholesterolemia, and smoking) regulate the expression and activity of NADPH oxidases in the vessel wall. RECENT ADVANCES: There are seven isoforms in mammals: Nox1, Nox2, Nox3, Nox4, Nox5, Duox1 and Duox2. Nox1, Nox2, Nox4, and Nox5 are expressed in endothelium, vascular smooth muscle cells, fibroblasts, or perivascular adipocytes. Other homologues have not been found or are expressed at very low levels; their roles have not been established. Nox1/Nox2 promote the development of endothelial dysfunction, hypertension, and inflammation. Nox4 may have a role in protecting the vasculature during stress; however, when its activity is increased, it may be detrimental. Calcium-dependent Nox5 has been implicated in oxidative damage in human atherosclerosis. CRITICAL ISSUES: NADPH oxidase-derived ROS play a role in vascular pathology as well as in the maintenance of normal physiological vascular function. We also discuss recently elucidated mechanisms such as the role of NADPH oxidases in vascular protection, vascular inflammation, pulmonary hypertension, tumor angiogenesis, and central nervous system regulation of vascular function and hypertension. FUTURE DIRECTIONS: Understanding the role of individual oxidases and interactions between homologues in vascular disease is critical for efficient pharmacological regulation of vascular NADPH oxidases in both the laboratory and clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–213 of 213
Fenyo, I. M., Albulescu, I. C., Raicu, M., & Manea, A. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.03.006 · Cited by 42
Nox2 and Nox4 mediate tumour necrosis factor-α-induced ventricular remodelling in mice
Moe, K. T., Yin, N. O., Naylynn, T. M., Khairunnisa, K., Wutyi, M. A., Gu, Y., Atan, M. S. M., Wong, M. C. S., Koh, T. H., & Wong, P. E. H. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01261.x · Cited by 41
Long-Term Cyclic Strain Downregulates Endothelial Nox4
Goettsch, C., Göettsch, W., Arsov, A., Hofbauer, L. C., Bornstein, S. R., & Morawietz, H. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2561 · Cited by 40
Bäumer, A. T., Krüger, C. A., Falkenberg, J., ten Freyhaus, H., Rösen, R., Fink, K., & Rosenkranz, S. (2007) · Clinical and Experimental Hypertension · doi:10.1080/10641960701500398 · Cited by 40
Rius, C., Piqueras, L., Navarro, H. G., Albertos, F., López‐Ginés, C., Ludwig, A., Blanes, J.-I., Morcillo, E. J., & Sanz, M. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.254870 · Cited by 35
Ding, L., Chapman, A., Boyd, R., & Wang, H. D. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00388.2006 · Cited by 31
Tripterine prevents endothelial barrier dysfunction by inhibiting endogenous peroxynitrite formation
Wu, F. Y., Han, M. H., & Wilson, J. X. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00292.x · Cited by 27
Fu, R., Wang, Q., Guo, Q., Xu, J., & Wu, X. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.08.004 · Cited by 25
Fluoroscopic Diagnosis of Native Valve Endocarditis
Raman, S. V., Bacon, J. P., Magorien, R. D., & Eaton, G. M. (2001) · Circulation · doi:10.1161/hc4001.096828 · Cited by 23
Noxa1 as a moderate activator of Nox2-based NADPH oxidase
Kawano, M., Miyamoto, K., Kaito, Y., Sumimoto, H., & TAMURA, M. N. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.12.025 · Cited by 19
Seasonal Reduction in Physical Activity and Flow-Mediated Dilation in Children
Hopkins, N. D., Stratton, G., Tinken, T. M., Ridgers, N. D., Graves, L., McWhannell, N., Cable, N. T., & GREEN, D. J. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181ebe90e · Cited by 18
Konior, A., Klemenska, E., Brudek, M., Podolecka, E., Czarnowska, E., & Berȩsewicz, A. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.11.010 · Cited by 16
Self-citationRegulation of Adhesion Molecules: A New Target for the Treatment of Chronic Venous Insufficiency
Verbeuren, T. J., Bouskela, E., Cohen, R. A., & Vanhoutte, P. M. (2000) · Microcirculation · doi:10.1111/j.1549-8719.2000.tb00150.x · Cited by 8
Cited by
Manna, P., & Jain, S. K. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0095 · Cited by 1,145
NADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology
Vermot, A., Petit-Härtlein, I., Smith, S. M. E., & Fieschi, F. (2021) · Antioxidants · doi:10.3390/antiox10060890 · Cited by 766
Oxidative Stress, Inflammation, and Vascular Aging in Hypertension
Guzik, T. J., & Touyz, R. M. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.07802 · Cited by 766
Self-citationMechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease
Donato, A. J., Machin, D. R., & Lesniewski, L. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.312563 · Cited by 688
NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
Zhang, Y., Murugesan, P., Huang, K., & Cai, H. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0260-8 · Cited by 534
Metadata
- Authors
- Konior, A., Schramm, A., Czesnikiewicz-Guzik, M., & Guzik, T. J.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2014-06-10
- Volume
- 20
- Issue
- 17
- Pages
- 2794-2814
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W1991416826
- Cited by
- 452
- References
- 213
- FWCI
- 18.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.